Company news

Beijing Wandong Medical Technology Co., Ltd. Class A (SSE:600055) news

Beijing Wandong Medical Technology Co., Ltd. Class A news releases on 6ix. Latest, Sep 1, 2026: "Beijing Wandong Medical Technology Co., Ltd."Announcement…

View Beijing Wandong Medical Technology Co., Ltd. Class A →

Press releases & updates

"Beijing Wandong Medical Technology Co., Ltd."Announcement on Progress in Using Idle Raised Funds and Self-owned Funds for Cash Management by the Company and Its Subsidiary

August 31, 2026

"Beijing Wandong Medical Technology Co., Ltd."Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026

August 28, 2026

"Beijing Wandong Medical Technology Co., Ltd."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026

August 25, 2026

"Beijing Wandong Medical Technology Co., Ltd."Notice on Convening the 2nd Extraordinary General Meeting in 2026

August 7, 2026

"Beijing Wandong Medical Technology Co., Ltd."Announcement on Obtaining of Medical Device Registration Certificate

July 31, 2026

"Beijing Wandong Medical Technology Co., Ltd."Semi-annual Performance Forecast for 2026

July 10, 2026

"Beijing Wandong Medical Technology Co., Ltd."Announcement on Implementation Result of Shares Repurchase and Share Changes

June 30, 2026

Announcement on the Completion of Cancellation of Some Stock Options under the 2025 Stock Option Incentive Plan

June 3, 2026

Announcement on Progress in the Company and Subsidiary Using Idle Raised Funds and Self-owned Funds for Cash Management

June 1, 2026

Announcement on Non-fulfillment of Exercise Conditions and Cancellation of Initial and Reserved Granting of Partial Stock Options in 1st Exercise Period of 2025 Stock Option Incentive Plan

May 22, 2026

Announcement on Progress in Repurchasing Shares

May 6, 2026

Announcement on Outward Investing in Establishing a Wholly-owned Subsidiary

April 24, 2026

Announcement on Resolutions of the 2025 Annual General Meeting

April 21, 2026

Announcement on Convening Performance Briefing for 2025 and Q1 2026

April 14, 2026

Announcement on Using Some Temporarily Idle Raised Funds and Self-owned Funds for Cash Management

March 25, 2026

Announcement on Obtaining of Medical Device Registration Certificate

March 17, 2026

Announcement on Resignation and By-election of Employee Director

March 9, 2026

Earnings Preannouncement for 2025

January 30, 2026

Announcement on Resolutions of the 13th Meeting of the 10th Board of Directors

January 26, 2026

Announcement on Acquisition of Controlling Shareholder's Assets and the New Commitment to Avoid Horizontal Competition

January 13, 2026

Announcement on Resolutions of the 12th Meeting of the 10th Board of Directors

January 9, 2026

Announcement on Progress in Company and Subsidiary Using Idle Raised Funds and Self-owned Funds for Cash Management

December 1, 2025

Announcement on Convening the Q3 2025 Performance Briefing

October 24, 2025

Announcement on Grant Results of the Reserved Part of the 2025 Stock Option Incentive Plan

September 29, 2025

Announcement on Initially Repurchasing Shares Through Call Auction

September 25, 2025

Announcement on Progress in Repurchasing Shares through Call Auction

September 1, 2025

Announcement on Shareholdings of Top 10 Shareholders and Top 10 Holders of Shares Without Sales Restrictions Regarding Share Repurchase

August 28, 2025

Announcement on Plan for Repurchasing Shares through Call Auction

August 22, 2025

Announcement on Completion and Termination of Stock Sales under the 2022 Employee Stock Ownership Plan

June 27, 2025

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025

June 9, 2025

Announcement on Completion of Grant Registration of the 2025 Stock Option Incentive Plan

May 30, 2025

Announcement on Resignation and Election of Chairman

May 21, 2025

Announcement on Implementation of Dividend Distribution for 2024

May 8, 2025

Report for Q1 2025

April 25, 2025

Announcement on Resolution of 2024 Annual General Meeting

April 16, 2025

Board of Supervisors' Remarks on Verification Opinions on and Publicity of List of Incentive Objects under Stock Option Incentive Plan

April 9, 2025

Announcement on 2024 Annual Profit Distribution Plan

March 21, 2025

Announcement on Circulation of Restricted Shares in Non-public Offering

March 18, 2025

Announcement on the Progress of Cash Management Using Idle Self-owned Funds by the Company and Its Subsidiaries

February 27, 2025

Announcement on Postponing Some Investment Projects Financed by Raised Funds

December 20, 2024

Announcement on Obtaining Medical Device Registration Certificate

November 25, 2024

Announcement on Convening the Q3 2024 Performance Briefing

October 25, 2024

Announcement on Convening 2024 Semi-annual Performance Meeting

August 16, 2024